AI Insight
Researchers at The University of Texas MD Anderson Cancer Center found that radiation therapy administered before surgery for brain metastases does more than kill tumor cells directly. The treatment also activates immune pathways within the tumor microenvironment, potentially making these tumors more responsive to subsequent immunotherapy treatments.
Why it matters
This finding could lead to improved treatment strategies for patients with brain metastases by combining radiation therapy with immunotherapy in a specific sequence. The research suggests a biological rationale for integrating these two treatment modalities to enhance overall therapeutic outcomes.
A new study led by researchers at The University of Texas MD Anderson Cancer Center demonstrated that preoperative radiation therapy for brain metastases not only targets tumor cells directly but also can activate immune pathways that can make tumors more receptive to immunotherapy.
Source: Radiation therapy enhances immune environment in brain metastases, improving treatment response